A collaborative intervention model involving a clinical pharmacist significantly reduces severe hypoglycemia risk without compromising glycemic control.

The usefulness and relevance of diabetes clinical guidelines are beyond doubt. Their use is widespread among internal medicine clinicians, though they have a weakness: “The most relevant information ...

Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat ...

Living with diabetes doesn’t have to mean accepting a lifetime of increasing medication doses and constant worry about blood sugar spikes. While traditional medical approaches focus heavily on ...

A new class of drug for type 2 diabetes could save thousands of lives each year, a study has found. Researchers described the once-daily SGLT-2 inhibitor tablets as working “very well” for a wide ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...

The Food and Drug Administration recently approved Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR for first-line use to improve glycemic control in diabetic adults when paired with diet and ...

W hen first diagnosed with type 2 diabetes, you may have been able to manage blood sugar levels with diet, exercise, and a first-line medication. But as the condition progresses, the body becomes more ...

You might have heard about medications like Ozempic®, Mounjaro®, and metformin for weight loss. But these drugs are actually diabetes medications that are sometimes prescribed off-label for weight ...